To check the effect of intravenous atropine in patients undergoing elective caesarean section for treating nausea and vomiting associated with spinal anaesthesia
Not Applicable
- Conditions
- Health Condition 1: O749- Complication of anesthesia duringlabor and delivery, unspecified
- Registration Number
- CTRI/2023/11/059735
- Lead Sponsor
- Dr Jai Prakash Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA II-III parturients undergoing elective LSCS under subarachnoid block in whom T6 or above level will be achieved and complains of nausea and/or vomiting
Exclusion Criteria
1) Non consenting patients
2) Drug hypersensitivity to atropine or ondansetron
3) Patients who already received anti-emetic/s within previous 6 hours
4) Patient having previous history of pre-eclampsia, eclampsia or hyperemesis gravidarum
5) Patients heart rate more than 120 beats/minute at the time of atropine administration
6) Patients undergoing elective caesarean section under general anaesthesia
7) Patients with bradycardia who already received atropine
8) Cognitively impaired
9) Age <18 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method